1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N2149
    Tomatidine

    番茄碱

    Inhibitor ≥98.0%
    Tomatidine 通过阻断 NF-κBJNK 信号发挥抗炎作用。Tomatidine 激活哺乳动物细胞或秀丽隐杆线虫中的自噬 (autophagy)。
    Tomatidine
  • HY-15122
    Sinomenine

    青藤碱

    Inhibitor 99.94%
    Sinomenine 是来自 Sinomenium acutum 的一种生物碱,是 NF-κB 活化的阻断剂。Sinomenine 也是 μ 阿片受体 (μ-opioid receptor) 激活剂。
    Sinomenine
  • HY-N0622
    Morusin

    桑辛素

    Inhibitor 99.94%
    Morusin是从Morus alba Linn.分离的去乙烯基化黄酮,具有抗肿瘤,抗氧化,抗菌等各种生物活性。Morusin可抑制 NF-κBSTAT3 的活性。
    Morusin
  • HY-112433
    NIK SMI1 Inhibitor 99.95%
    NIK SMI1 是一种有效的选择性 NF-κB 诱导激酶 (NIK) 抑制剂,可抑制 NIK 催化的 ATP 水解为 ADP,IC50 为 0.23±0.17 nM。
    NIK SMI1
  • HY-N1913
    Danshensu

    丹参素

    Inhibitor 98.59%
    Danshensu (Dan shen suan A) 是一种具有口服活性的酚类化合物,可诱导 Nrf2/HO-1 激活并抑制 NF-κB 通路。Danshensu 可减少活性氧 (ROS) 的产生,上调抗氧化防御机制并抑制内在的细胞凋亡途径。Danshensu 对 SARS-CoV-2 显示出有效的抗病毒活性,EC50 为 0.97 μM。Danshensu 具有抗氧化、抗凋亡、抗肺部炎症等作用,具有用于 COVID-19、心脑血管等疾病研究的潜力。
    Danshensu
  • HY-N0108
    Physcion

    大黄素甲醚

    Inhibitor 99.10%
    Physcion (Parietin) 是从中药大黄中得到的蒽醌类物质,是具有口服有效性和血脑屏障透过性的 6-磷酸葡萄糖酸脱氢酶 (6-phosphogluconate dehydrogenase) 抑制剂,IC50Kd 值分别为 38.5 μM 和 26.0 μM。同时,Physcion 也是 TLR4/NF-kB 信号通路抑制剂,具有抗炎、抗菌、抗癌作用,可诱导癌细胞凋亡 (Apoptosis) 和自噬 (Autophagy)。
    Physcion
  • HY-P1098A
    Ac2-26 TFA Inhibitor 99.67%
    Ac2-26 TFA,是 annexin 1 的 N 末端肽,具有抗炎活性。Ac2-26 通过伴侣介导的自噬 (CMA) 诱导溶酶体中 IKKβ 蛋白的减少。Ac2-26 可改善肺缺血再灌注损伤。Ac2-26 还可抑制哮喘大鼠模型的气道炎症和高反应性。
    Ac2-26 TFA
  • HY-N0633
    Muscone

    麝香酮

    Inhibitor ≥98.0%
    Muscone 是中药麝香的主要活性单体。Muscone 抑制 NF-κBNLRP3 炎性小体的活化。Muscone 显着降低炎性细胞因子 (IL-1βTNF-αIL-6) 水平,并最终改善心脏功能和存活率。
    Muscone
  • HY-N0708
    Vanillic acid

    香草酸

    Inhibitor 99.75%
    Vanillic acid 是一种在食用植物和水果中发现的调味剂,在当归根部也可以发现。Vanillic acid 抑制 NF-κB 活化。具有抗炎,抗菌等活性。
    Vanillic acid
  • HY-N2515
    Ginsenoside Rk1

    人参皂苷

    Inhibitor 99.90%
    Ginsenoside Rk1 人参皂苷 Rk1 是人参的高温加工提取物。 Ginsenoside Rk1 具有抗炎作用,抑制 Jak2/Stat3 信号通路和 NF-κB 的激活。 Ginsenoside Rk1 具有抗肿瘤作用,抗血小板聚集活性,抗炎作用,抗胰岛素抵抗,肾保护作用,抗菌作用,认知功能增强,脂质积聚减少和预防骨质疏松症。 Ginsenoside Rk1 通过触发细胞内活性氧 (ROS) 生成和阻断 PI3K/Akt 途径诱导细胞凋亡。
    Ginsenoside Rk1
  • HY-N0492
    α-Lipoic Acid

    α-硫辛酸

    Inhibitor 99.86%
    α-Lipoic Acid (Thioctic acid) 是一种抗氧化剂,是线粒体酶复合物的重要辅助因子。α-Lipoic Acid 可抑制 NF-κB 依赖性的 HIV-1 LTR 活化。α-Lipoic Acid 诱导内质网应激 (ERS) 介导的肝癌细胞凋亡 (apoptosis)。α-Lipoic Acid 可与 CPUL1 (HY-151802) 合成自组装的纳米聚合体 CPUL1-LA NA,其抗肿瘤效果优于 CPUL1。
    α-Lipoic Acid
  • HY-17473
    Embelin

    恩贝酸

    Inhibitor 98.75%
    Embelin (Embelic acid) 是一种有效的、非肽类的细胞渗透性 XIAP 抑制剂 (IC50=4.1 μM),在高水平 XIAP 的前列腺癌细胞中抑制细胞生长,诱导凋亡 (apoptosis),并激活 caspase-9。Embelin 阻断 NF-kappaB 信号通路,从而抑制 NF-kappaB 调节的抗凋亡和转移基因产物。Embelin 诱导口腔鳞癌细胞自噬和凋亡。
    Embelin
  • HY-B0008
    Sulindac

    舒林酸

    Inhibitor 99.81%
    Sulindac (MK-231) 是一种口服活性非甾体类抗炎药。Sulindac 也是一种免疫调节剂。Sulindac 可用于脊柱关节炎、痛风性关节炎及多种癌症如结直肠癌、肺癌的研究。
    Sulindac
  • HY-N0787
    Cryptochlorogenic acid

    隐绿原酸

    Inhibitor 99.87%
    Cryptochlorogenic acid (4-Caffeoylquinic acid) 是一种具有口服有效性的天然存在的酚酸类化合物,具有抗炎、抗氧化和抗心肌肥大作用,能通过调控促炎因子表达、抑制 NF-κB 活性、促进 Nrf2 核转移以及调节 PI3Kα/Akt/ mTOR / HIF-1α 信号通路来减轻 LPS (HY-D1056) 和 ISO (HY-B0468) 诱导的生理应激反应。
    Cryptochlorogenic acid
  • HY-19357
    E3330 Inhibitor 99.34%
    E3330 (APX-3330) 是一种直接,口服有效的,选择性的 Ape-1 (无嘌呤/嘧啶内切酶 1)/Ref-1 (氧化还原因子 -1) 氧化还原的抑制剂。E3330 能抑制胰腺癌组织中 NF-κBAP-1HIF-1α 的活性。E3330 具有抗癌活性。
    E3330
  • HY-P9958
    Denosumab

    地舒单抗

    Inhibitor 99.10%
    Denosumab 是一种靶向 RANKL 蛋白的人单克隆抗体。Denosumab 结合 receptor activator of nuclear factor kappa-B ligand (RANKL) 并阻止其与 RANK 受体结合 (对人 RANKL 的 KD 为 0.003 nM)。Denosumab 促进增殖和精子发生。Denosumab 通过抑制 NF-κB 途径防止骨吸收。Denosumab 可用于骨相关研究。
    Denosumab
  • HY-N0587
    Demethylzeylasteral

    去甲泽拉木醛

    Inhibitor 99.92%
    Demethylzeylasteral 是一种从雷公藤中分离出来的口服有效的三萜类化合物,具有抗炎、抗肿瘤、抗生育、雌激素代谢调节、免疫抑制和免疫系统调节等功能。
    Demethylzeylasteral
  • HY-N0441
    Neferine

    甲基莲心碱

    Inhibitor 99.92%
    Neferine 是一种双苄基异喹啉类生物碱。Neferine 强效抑制 NF-κB 激活。
    Neferine
  • HY-15122A
    Sinomenine hydrochloride

    盐酸青藤碱

    Inhibitor 98.67%
    Sinomenine hydrochloride (Cucoline hydrochloride) 是来自?Sinomenium acutum 的一种生物碱,是 NF-κB 活化的阻断剂。Sinomenine 也是 μ 阿片受体 (μ-opioid receptor) 激活剂。
    Sinomenine hydrochloride
  • HY-128853
    Taurodeoxycholate sodium salt

    牛磺脱氧胆酸钠

    Inhibitor 99.80%
    Taurodeoxycholate sodium salt 是一种胆盐相关的阴离子洗涤剂。Taurodeoxycholate sodium salt 是在肝脏中将脱氧胆酸与 Taurine (HY-B0351) 偶联形成的。Taurodeoxycholate sodium salt 可用于分离膜蛋白,包括线粒体内膜蛋白。Taurodeoxycholate (TDCA) 具有抗炎和神经保护作用。。
    Taurodeoxycholate sodium salt
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.